Canada markets closed

Alpha Cognition Inc. (ACOGF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.8817+0.0217 (+2.52%)
At close: 03:20PM EST
Full screen
Loading interactive chart...
  • Business Wire

    Alpha Cognition Appoints Cedric O’Gorman, M.D., MBA as Chief Medical Officer

    VANCOUVER, British Columbia, December 02, 2021--Alpha Cognition Inc. (TSX-V: ACOG)(OTCQB: ACOGF)("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today announced the appointment of Cedric O’Gorman, M.D., as the Company’s Chief Medical Officer. Dr. O’Gorman will lead medical, clinical and regulatory functions in support of the company's clinic

  • Business Wire

    Alpha Cognition Reports Third Quarter of Fiscal 2021 Results

    VANCOUVER, British Columbia, November 30, 2021--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB:ACOGF) ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce that it has reported its Third Quarter financial results of fiscal 2021.

  • Business Wire

    Alpha Cognition to Present at LD Micro Main Event

    VANCOUVER, British Columbia, October 08, 2021--Alpha Cognition Inc. (TSX-V: ACOG)(OTCQB: ACOGF)("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce that it will be presenting at the 14th annual Main Event on Tuesday, October 12th at 3:00 PM EST at the Luxe Sunset Bel-Air in Los Angeles. Michael McFadden, CEO of Alpha Cogni